1. Lahmer T, Treiber M, von Werder A, Foerger F, Knopf A, Heemann U, et al. Relapsing polychondritis: An autoimmune disease with many faces. Autoimmunity reviews. 2010;9(8):540-6.
2. Pearson CM, Kline HM, Newcomer VD. Relapsing polychondritis. N Engl J Med. 1960;263:51-8.
3. Hazra N, Dregan A, Charlton J, Gulliford MC, D'Cruz DP. Incidence and mortality of relapsing polychondritis in the UK: a population-based cohort study. Rheumatology (Oxford, England). 2015;54(12):2181-7.
4. Mathew SD, Battafarano DF, Morris MJ. Relapsing polychondritis in the Department of Defense population and review of the literature. Seminars in arthritis and rheumatism. 2012;42(1):70-83.
5. Gergely P, Poór G. Relapsing polychondritis. Best Pract Res Clin Rheumatol. 2004;18(5):723-38.
6. Kent PD, Michet CJ, Luthra HS. Relapsing polychondritis. Curr Opin Rheumatol. 2004;16(1):56-61.
7. McAdam LP, O'Hanlan MA, Bluestone R, Pearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine. 1976;55(3):193-215.
8. Damiani JM, Levine HL. Relapsing polychondritis--report of ten cases. The Laryngoscope. 1979;89(6 Pt 1):929-46.
9. Michet CJ, McKenna CH, Luthra HS, O'Fallon WM. Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med. 1986;104(1):74-8.
10. de Montmollin N, Dusser D, Lorut C, Dion J, Costedoat-Chalumeau N, Mouthon L, et al. Tracheobronchial involvement of relapsing polychondritis. Autoimmunity reviews. 2019;18(9):102353.
11. Shimizu J, Oka H, Yamano Y, Yudoh K, Suzuki N. Cardiac involvement in relapsing polychondritis in Japan. Rheumatology (Oxford, England). 2016;55(3):583-4.
12. Vitale A, Sota J, Rigante D, Lopalco G, Molinaro F, Messina M, et al. Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives. Current rheumatology reports. 2016;18(1):3.
13. Arnaud L, Mathian A, Haroche J, Gorochov G, Amoura Z. Pathogenesis of relapsing polychondritis: a 2013 update. Autoimmunity reviews. 2014;13(2):90-5.
14. Ebringer R, Rook G, Swana GT, Bottazzo GF, Doniach D. Autoantibodies to cartilage and type II collagen in relapsing polychondritis and other rheumatic diseases. Annals of the rheumatic diseases. 1981;40(5):473-9.
15. Foidart JM, Abe S, Martin GR, Zizic TM, Barnett EV, Lawley TJ, et al. Antibodies to type II collagen in relapsing polychondritis. N Engl J Med. 1978;299(22):1203-7.
16. Hansson AS, Heinegård D, Piette JC, Burkhardt H, Holmdahl R. The occurrence of autoantibodies to matrilin 1 reflects a tissue-specific response to cartilage of the respiratory tract in patients with relapsing polychondritis. Arthritis and rheumatism. 2001;44(10):2402-12.
17. Mathian A, Miyara M, Cohen-Aubart F, Haroche J, Hie M, Pha M, et al. Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best Pract Res Clin Rheumatol. 2016;30(2):316-33.
18. Ernst A, Rafeq S, Boiselle P, Sung A, Reddy C, Michaud G, et al. Relapsing polychondritis and respiratory involvement. Chest. 2009;135(4):1024-30.
19. Dion J, Costedoat-Chalumeau N, Sène D, Cohen-Bittan J, Leroux G, Dion C, et al. Relapsing Polychondritis Can Be Characterized by Three Different Clinical Phenotypes: Analysis of a Recent Series of 142 Patients. Arthritis & rheumatology (Hoboken, NJ). 2016;68(12):2992-3001.
20. Shimizu J, Yamano Y, Kawahata K, Suzuki N. Relapsing polychondritis patients were divided into three subgroups: patients with respiratory involvement (R subgroup), patients with auricular involvement (A subgroup), and overlapping patients with both involvements (O subgroup), and each group had distinctive clinical characteristics. Medicine. 2018;97(42):e12837.
21. Thaiss WM, Nikolaou K, Spengler W, Spira D, Xenitidis T, Henes J, et al. Imaging diagnosis in relapsing polychondritis and correlation with clinical and serological data. Skeletal radiology. 2016;45(3):339-46.
22. Rafeq S, Trentham D, Ernst A. Pulmonary manifestations of relapsing polychondritis. Clin Chest Med. 2010;31(3):513-8.
23. Lee KS, Ernst A, Trentham DE, Lunn W, Feller-Kopman DJ, Boiselle PM. Relapsing polychondritis: prevalence of expiratory CT respiratory abnormalities. Radiology. 2006;240(2):565-73.
24. Ananthakrishna R, Goel R, Padhan P, Mathew J, Danda D. Relapsing polychondritis--case series from South India. Clinical rheumatology. 2009;28 Suppl 1:S7-10.
25. Zhang L, Yun S, Wu T, He Y, Guo J, Han L, et al. Clinical patterns and the evolution of relapsing polychondritis based on organ involvement: a Chinese retrospective cohort study. Orphanet journal of rare diseases. 2021;16(1):225.
26. Ferrada MA, Grayson PC, Banerjee S, A Sikora K, A Colbert R, Sinaii N, et al. Patient Perception of Disease-Related Symptoms and Complications in Relapsing Polychondritis. Arthritis Care Res (Hoboken). 2018;70(8):1124-31.
27. Chang-Miller A, Okamura M, Torres VE, Michet CJ, Wagoner RD, Donadio JV, et al. Renal involvement in relapsing polychondritis. Medicine. 1987;66(3):202-17.
28. Yang W-M, Zhang W-H, Ying H-Q, Xu Y-M, Zhang J, Min Q-H, et al. Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio. Int Immunopharmacol. 2018;62:293-8.
29. Soliman WM, Sherif NM, Ghanima IM, El-Badawy MA. Neutrophil to lymphocyte and platelet to lymphocyte ratios in systemic lupus erythematosus: Relation with disease activity and lupus nephritis. Reumatol Clin (Engl Ed). 2020;16(4):255-61.
30. Cao X, Zhao M, Li H, Xu D, Li M, Zhang X, et al. Three new inflammatory markers C reactive protein to albumin ratio, neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio correlated with relapsing polychondritis disease activity index. Clinical rheumatology. 2021.